An expanding portfolio of targeted next generation sequencing panels and library preparation reagents.
The complete array solution for clinical genetics research, including accurate and sensitive products and fully accredited service options.
31 May 2017
OGT to be acquired by Sysmex Corporation
OGT to be acquired by Sysmex Corporation, a leading provider of haematology and in vitro diagnostics products
25 April 2017
OGT’s expanded NGS cancer panels enable sequencing of difficult genes